Web1 hour ago · Dealings in securities by an associate of a director Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis Health” or “the Company”) DEALINGS IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR In compliance with paragraphs … WebMar 31, 2024 · Cambridge Investment Research, Securities America and J.W. Cole Financial failed to see the risk as reps sold options-laden 'short-vol' LJM Preservation and Growth Fund to investors ...
2241. Research Analysts and Research Reports FINRA.org
WebOct 17, 2024 · See FINRA’s Regulatory Notice 21-41 for more details. Firm Element CE Changes. ... Covered registered persons are registered persons who work with customers, who are registered as research analysts, and individuals who supervise such persons. In addition, training related to the anti-money laundering compliance program under Rule … WebSep 11, 2015 · FINRA has also achieved its long-stated objective of establishing a debt research rule. New FINRA Rule 2242 (the “Debt Rule”) carries over most requirements in the Current Equity Rules, but with modifications. Notably, the Debt Rule will apply a tiered approach to certain requirements. Debt research provided solely to certain eligible ... natures agro products
Gary Mottola - Research Director, Office of Investor …
Webwithin the definition of “research report” under FINRA Rule 2241); and Other research that does not meet the definition of “research report” under FINRA Rule 2241(a)(11),3 provided that the Supervisory Analyst has technical expertise in the particular product area. 1 FINRA Regulatory Notice 12-29 (“Notice 12-29”), found at https ... WebCAMBRIDGE INVESTMENT RESEARCH, INC. CRD# 39543 SEC# 8-48740 Main Office Location 1776 PLEASANT PLAIN RD. FAIRFIELD, IA 52556-8757 Regulated by FINRA Kansas City Office WebMar 29, 2024 · FINRA has an overall rating of 4.1 out of 5, based on over 953 reviews left anonymously by employees. 88% of employees would recommend working at FINRA to a friend and 82% have a positive outlook for the business. This rating has decreased by -3% over the last 12 months. natures advocates rspb